|
Form 4 Filings | Insider Buys | Significant Buys |
Penny Stocks Insider Buying |
Insider Sales |
| Insider Buy Sell Ratios | Stock Options |
Insider Trading Stock Screener |
Insider Trading Graph View |
Insider Watch |
Insider Trading - MADRIGAL PHARMACEUTICALS Inc (MDGL)
|
|
"Insiders might sell their shares for any number of reasons, but they buy them for only one:
they think the price will rise"
- Peter Lynch What is insider trading>> |
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2018-11-20 Purchase |
2018-11-23 8:53 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO |
4,000 | $117.9 | $471,520 | 161,128 (Direct) |
View |
| 2018-11-19 Purchase |
2018-11-19 6:26 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO |
4,000 | $124 | $496,000 | 157,128 (Direct) |
View |
| 2018-11-19 Purchase |
2018-11-19 6:09 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director, 10% Owner |
2,000 | $124.7 | $249,387 | 298,067 (Direct) |
View |
| 2018-06-11 Sale |
2018-06-13 3:53 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
10,099 | $287.5 | $2,903,058 | 51,767 (Direct) |
View |
| 2018-06-11 Sale |
2018-06-12 9:02 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director, 10% Owner |
280,000 | $287.5 | $80,488,798 | 5,264,382 (Indirect) |
View |
| 2018-06-11 Sale |
2018-06-12 8:56 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO |
73,526 | $287.5 | $21,135,783 | 655,540 (Indirect) |
View |
| 2018-06-11 Sale |
2018-06-12 8:55 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Chief Medical Officer, EVP R&D |
73,526 | $287.5 | $21,135,783 | 655,540 (Indirect) |
View |
| 2018-06-11 Sale |
2018-06-12 8:50 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | BAY CITY CAPITAL LLC Director, 10% Owner |
280,000 | $287.5 | $80,488,798 | 5,264,382 (Indirect) |
View |
| 2017-08-23 Purchase |
2017-08-24 4:04 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director |
2,000 | $16.12 | $32,236 | 9,100 (Direct) |
View |
| 2017-08-22 Purchase |
2017-08-23 4:03 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director |
3,550 | $16.12 | $57,209 | 7,100 (Direct) |
View |
| 2017-08-21 Purchase |
2017-08-22 4:05 pm |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director |
3,550 | $15.88 | $56,358 | 3,550 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2019-07-10 Option Award |
2019-07-11 11:28 am |
N/A 2029-07-10 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca President |
8,000 | $101.3 | 8,000 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 5:59 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director |
10,000 | $100.4 | 10,000 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 5:58 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | BATE KENNETH Director |
10,000 | $100.4 | 10,000 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 5:55 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Daly James M Director |
20,000 | $100.4 | 20,000 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 5:47 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director, 10% Owner |
10,000 | $100.4 | 10,000 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 5:39 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Gollust Keith R Director |
10,000 | $100.4 | 10,000 (Direct) |
View |
| 2019-06-27 Option Award |
2019-07-01 5:13 pm |
N/A 2024-06-27 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director |
10,000 | $100.4 | 10,000 (Direct) |
View |
| 2019-03-07 Option Award |
2019-03-11 3:42 pm |
N/A 2029-03-07 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Chief Medical Officer, EVP R&D |
38,000 | $128 | 38,000 (Direct) |
View |
| 2019-03-07 Option Award |
2019-03-11 3:42 pm |
N/A 2029-03-07 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO |
50,000 | $128 | 50,000 (Direct) |
View |
| 2019-03-07 Option Award |
2019-03-11 3:41 pm |
N/A 2029-03-07 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
28,000 | $128 | 28,000 (Direct) |
View |
| 2018-11-14 Exercise |
2018-11-14 6:43 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director |
10,000 | $16.46 | 30,000 (Direct) |
View |
| 2018-11-14 Exercise |
2018-11-14 6:43 pm |
2018-06-29 2027-06-29 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director |
10,000 | $16.46 | 30,000 (Direct) |
View |
| 2018-09-18 Exercise |
2018-09-19 4:25 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director |
20,000 | $9.45 | 20,000 (Direct) |
View |
| 2018-09-18 Exercise |
2018-09-19 4:25 pm |
2017-07-22 2026-07-22 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director |
20,000 | $9.45 | 20,000 (Direct) |
View |
| 2018-06-19 Option Award |
2018-06-21 8:52 pm |
N/A 2028-06-19 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | BATE KENNETH Director |
10,000 | $303.8 | 10,000 (Direct) |
View |
| 2018-06-19 Option Award |
2018-06-21 7:03 pm |
N/A 2028-06-19 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Levy Richard S Director |
10,000 | $303.8 | 10,000 (Direct) |
View |
| 2018-06-19 Option Award |
2018-06-21 7:00 pm |
N/A 2028-06-19 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | MILLIGAN DAVID V Director |
10,000 | $303.8 | 10,000 (Direct) |
View |
| 2018-06-19 Option Award |
2018-06-21 7:00 pm |
N/A 2028-06-19 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Gollust Keith R Director |
10,000 | $303.8 | 10,000 (Direct) |
View |
| 2018-06-19 Option Award |
2018-06-21 7:00 pm |
N/A 2028-06-19 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | CRAVES FRED B Director, 10% Owner |
10,000 | $303.8 | 10,000 (Direct) |
View |
| 2018-06-11 Exercise |
2018-06-13 3:53 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
5,223 | $99.75 | 51,767 (Direct) |
View |
| 2018-06-11 Exercise |
2018-06-13 3:53 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
2,734 | $61.6 | 51,767 (Direct) |
View |
| 2018-06-11 Exercise |
2018-06-13 3:53 pm |
2015-12-08 2024-12-08 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
5,223 | $99.75 | 51,767 (Direct) |
View |
| 2018-06-11 Exercise |
2018-06-13 3:53 pm |
2016-10-02 2025-10-02 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
2,734 | $61.6 | 51,767 (Direct) |
View |
| 2018-03-01 Option Award |
2018-03-05 12:47 pm |
N/A 2028-03-01 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Schneebaum Marc R CFO |
28,000 | $124.4 | 28,000 (Direct) |
View |
| 2018-03-01 Option Award |
2018-03-05 12:47 pm |
N/A 2028-03-01 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | Taub Rebecca Chief Medical Officer, EVP R&D, 10% Owner |
38,000 | $124.4 | 38,000 (Direct) |
View |
| 2018-03-01 Option Award |
2018-03-05 12:46 pm |
N/A 2028-03-01 |
MADRIGAL PHARMACEUTICALS Inc | MDGL | FRIEDMAN PAUL A CEO |
50,000 | $124.4 | 50,000 (Direct) |
View |
|
© 2005-2019 SecForm4.Com All rights reserved. Archives: 2019 2018 2017 2016 2015 2014 ... Thu, 18 Jul 2019 14:58:52 -0500 |
SEC is the U.S. Securities and Exchange Commission. EDGAR is a trademark of the SEC.
SecForm4.Com is not affiliated with or approved by the U.S. Securities and Exchange Commission (SEC). Terms of Use | Privacy Statement | |